The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

BACKGROUND: Neuroendocrine markers, which could indicate for aggressive variants of prostate cancer and Ki67 (a well-known marker in oncology for defining tumor proliferation), have already been associated with clinical outcome in prostate cancer. The aim of this study was to investigate the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascale, Mariarosa, Aversa, Cinzia, Barbazza, Renzo, Marongiu, Barbara, Siracusano, Salvatore, Stoffel, Flavio, Sulfaro, Sando, Roggero, Enrico, Bonin, Serena, Stanta, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030813/
https://www.ncbi.nlm.nih.gov/pubmed/27679548
http://dx.doi.org/10.1515/raon-2016-0033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030813/
https://www.ncbi.nlm.nih.gov/pubmed/27679548
http://dx.doi.org/10.1515/raon-2016-0033

Ejemplares similares